Positron Emission Tomography (PET) is helping to provide MS experts some insight into what drives progression of the disease. PET also has the potential to quantify the effects of new, targeted therapies on MS patients, according to consultant neurologist Professor Bruno Stankoff.
Preliminary tests have demonstrated that a new device may enable existing breast cancer imagers to provide up to six times better contrast of tumors in the breast, while maintaining the same or better image quality and halving the radiation dose to patients. The advance is made possible by a new device developed for 3D imaging of the breast by researchers at the Department of Energy's Thomas…
Eckert & Ziegler AG, a specialist for isotope-based applications in medicine, science and industry, is expanding its cooperation program with promising drug developers in the field of nuclear medicine and will support Curasight, a spin-off based on research by the group of Professor Andreas Kjaer at the National University Hospital (Rigshospitalet) and University of Copenhagen, in obtaining…
The European Society of Radiology (ESR) is proud to announce the foundation of a new subspecialty society, the European Society for Hybrid Medical Imaging (ESHI).
Imaging modality complements a stress test in diagnosing the aetiology of chest pain, according to an expert speaking at the International Conference on Nuclear Cardiology and Cardiac CT (ICNC) held this May in Madrid.
Dr Gerald Antoch, professor of radiology and chairman of the department of diagnostic and interventional radiology at Düsseldorf University Hospital and active member of several scientific societies, delivered the prestigious Wilhelm Conrad Röntgen Honorary Lecture at ECR 2015 on ‘Hybrid imaging: Let the two worlds of radiology and nuclear medicine come together’. Report: Marcel Rasch
PET scanners are not the only way to image radiotracers. Recent work developed around a phenomenon called Cerenkov luminescence aims to bring a new modality out of preclinical development and into clinical practice.
Before 2013, when Professor Dietmar Dinter became partner of Radiologie Schwetzingen, a multi-discipline group practice specialised in radiology and nuclear medicine, he was senior resident at the Institute of Clinical Radiology and Nuclear Medicine at University Hospital Mannheim (2003-2012) and head of its Nuclear Medicine Department (2009-2012). Was his work in nuclear medicine altered by the…
Visiorad is an association of radiology, radiotherapy and nuclear medicine practices which serve the northwestern part of Hamburg and the adjacent suburban areas. Dr Timo Gomille, partner of Visiorad, and his team focus on breast diagnostics. A mainstay of their daily work is the RS80A – the Samsung ultrasound system which impresses with superior image quality and an innovative operating concept
Researchers from the University of Heidelberg and the German Cancer Research Center (DKFZ) have developed a new method that uses light to control processes in living cells.
Nuclear medicine (NM) is the second largest source of medical radiation exposure after CT. However, patients who had a NM examination a decade ago most likely received a higher radiation dose than a patient in 2013.
How the different advanced cardio vascular imaging technologies fit together in managing cardiac patients, will be one of the main themes explored at the International Conference on Nuclear Cardiology and Cardiac CT (ICNC 11).
Although most nuclear medical examinations using SPECT (single photon emission computed tomography) take place beyond hospitals, two to three times more SPECT exams than PET-CT exams are carried out within hospitals.
This technique is increasingly used to detect breast cancer and has been shown to improve diagnosis in many clinical situations. It is also allowing clinicians to detect previously unknown areas of breast cancer in women with newly diagnosed disease.
Currently there is a truly enormous hole in the ground in the city of Wiener Neustadt, Austria, but by summer 2012 MedAustron, one of the most modern centres for ion therapy and research in Europe, is to be built here.
Royal Philips Electronics is announcing 510(k) clearance from the Food and Drug Administration (FDA) for the company’s first commercially available whole body positron emission tomography/magnetic resonance (PET/MR) imaging system, the Ingenuity TF PET/MR.
It was not the sunshine of the Cote d’Azur in September that lured radiologists to picturesque Nice. Far more enticing was the stimulating programme offered by the Annual Scientific Meeting of Management in Radiology (MIR), which, for the first time, also included a Junior Radiologists Course.
In recent years, combined examination methods have increased, whereby two examination methods are used in a parallel examination, rather than performed separately. Frederik Giesel MD, Associate Professor of Radiology at the Nuclear Medicine Department, University of Heidelberg, and Philip Herold (Dipl. Econ.), Project Manager at RICT Heidelberg, report on the benefits.
2011 brought a second year for European and US scientists to meet up at the Annual Scientific Symposium on Ultra High Field Magnetic Resonance, held at the Max Delbrück Centre for Molecular Medicine Berlin-Buch (MDC), Germany, to present and discuss their recent findings. Along with technical improvements, the main issues of the one-day gathering were cardiac, cerebral and molecular MR imaging.…
A major public hospital has become the first in Paris to be equipped with a Gamma Knife, the device that enables the surgeon to operate on the brain with no blade or blood involved.
PredictAD is an EU-funded research project that develops objective and efficient methods for enabling earlier diagnosis of Alzheimer's disease. Diagnosis requires a holistic view of the patient combining information from several sources, such as, clinical tests, imaging and blood samples.
Every medical congress is an opportunity for the manufacturers to showcase their products. This year’s congress of the German Röntgen Society was no exception -- and one innovation particularly caught the attention of our European Hospital team: positron emission mammography, PEM for short.
CT-PET is the child of a forced marriage between nuclear medicine and radiology. A shared session at ECR 2011 in Vienna did little to assure there is a growing consensus between the two partners.
Although developments in molecular imaging still do not reach the high expectations placed upon them, the change in imaging is very obvious. Having been limited to the imaging of morphology, nowadays information on tissue characteristics, blood vessels or the metabolic behaviour of tumours provide many more insights, for example into response behaviour.